ArticleDiabetes & metabolism journal2023
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404).
Jihee Ko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.